The da Vinci surgical robot was the first robotic surgery system to gain approval through the U.S. Food and Drug Administration (FDA) in 2000. When it first appeared, its manufacturer, Intuitive Surgical, promised the da Vinci surgical robot would enhance surgeons’ precision during operations, improving outcomes for patients. According to the New England Journal of Medicine, the device was quickly adopted. Since 2007, the worldwide use of surgical robots has tripled. Unfortunately, there have been many reports of surgical complications with the da Vinci system, including burns, infections, organ punctures, tears, and even death.